LEXINGTON, Mass., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 2012 RBC Capital Markets’ Healthcare Conference at 1:35 p.m. EST on February 28, 2012, in New York City.
